Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder: A Randomized Controlled Trial
Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder: A Randomized Controlled Trial
This randomized controlled trial investigates the comparative effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy and selective serotonin reuptake inhibitors (SSRIs) in fostering post-traumatic growth among patients diagnosed with post-traumatic stress disorder (PTSD). Participants will be randomized to receive either EMDR therapy or standard SSRI pharmacotherapy. The primary objective is to evaluate the extent of psychological growth and recovery achieved through each intervention, aiming to guide future therapeutic strategies for PTSD.
Inclusion Criteria:
Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD) based on DSM-5 criteria
Willingness to participate and provide informed consent
Ability to comply with study procedures
Exclusion Criteria:
Current diagnosis of psychotic disorder, bipolar disorder, or severe major depressive episode with psychotic features
Active substance use disorder within the past 6 months
Severe cognitive impairment or inability to complete study assessments